Clinical Trials

Cancer Type

State

Phase

Treatment

Inhibitor

NCT 05756907 Brief Summary This is a Phase 1b/2a, open-label, adaptive-design outpatient…

Our support knows no limits, which means we do whatever it takes to be there for all you need.

How we help you View the Rare Cancer Support Guide

We have a friendly team available to chat about any questions you may have, or just to lend an ear if you’re having a tough time.

Call 1800 257 600 Have us call you